CerTest CLIA SARS-CoV-2 Plate is an antigen detection product.

Quantitative detection of SARS-CoV-2 antigen in human nasopharyngeal swabs specimens is possible with our plates.

CLIA technique is more sensitive that other immunological techniques, which is a great advantage in the rapid and accurate diagnosis of infectious diseases.

Clinically, patients with SARS-CoV-2 infection tend to suffer symptoms such as olfactory and gustatory dysfunction, fever, dry cough, ansomia, fatigue, dyspnoea, headache, diarrhoea and sore throat, followed by vascular and systematic complications. COVID-19 commonly results in pneumoia, which can evolve into acute respiratory distress syndrome, leading to respiratory or multiorgan failure.

On March 11, 2020, the WHO declared the disease a pandemic, due to the high number of infected people and the rapidity of tis spread worldwide.

CerTest CLIA SARS-CoV-2 plates are:

  • Accurate. CerTest CLIA technology is high accurate.
  • Adaptable to any CLIA plate analyzer.
  • Saving time and low manipulation. Plate, reagent, and samples are placed directly on the analyzer. No manipulation from technician is needed.
  • Easy interpretation. Positive or negative result will be programmed. Total RLUs will also be shown, so quantitative interpretation is possible.


Formato de ensayo
96 Well plates
Tipo de quimioluminiscencia
Fase sólida y conjugada
High specific monoclonals, developed by CerTest Biotec, S.L.
HRP label antibody
Liquid and stable, ready to use

¿Necesita más información?